-
CLK2 Inhibition and Platinum Resistance in Ovarian Cancer
2026-08-26
The reference study identifies Cdc2-like kinase 2 (CLK2) as a clinically relevant mediator of platinum resistance in ovarian cancer and links its activity to BRCA1 phosphorylation at Ser1423. By combining patient-tissue analysis, cellular assays, mechanistic studies, and xenograft experiments, the work establishes CLK2-dependent DNA-damage repair as a potential therapeutic vulnerability while highlighting the need for selective and clinically validated CLK2-directed strategies.
-
Calcium Effects on Amyloid-β Aggregation
2026-08-25
The reference study combines supercritical angle Raman and fluorescence spectroscopy with microscopy to examine how CaCl2 changes amyloid-β behavior at lipid membrane surfaces. Its central finding is that calcium can form a protective interfacial layer that limits peptide insertion, with a stronger effect on Aβ1–42 than on the 40-residue variant, while aggregation history remains an important experimental variable.
-
Amyloid Beta-Peptide (1-40): Assay Workflows
2026-08-25
Build more reproducible Aβ40 experiments with controlled reconstitution, time-resolved aggregation, membrane assays, and orthogonal readouts. This workflow also translates calcium-dependent surface behavior into better-designed cell and neurotoxicity studies.
-
Degarelix Acetate and Flare-Free Androgen Deprivation
2026-08-24
Laurence Klotz’s 2009 review examines degarelix acetate as a third-generation GnRH antagonist designed to produce rapid testosterone suppression without the flare associated with GnRH agonists. Its synthesis of phase II and phase III evidence highlights faster biochemical control, a broadly comparable safety profile, and the clinical importance of direct pituitary GnRH-receptor blockade in advanced prostate cancer.
-
MRSA EVs Drive IL-8–Dependent OSCC Growth
2026-08-24
The reference study shows that extracellular vesicles released by methicillin-resistant Staphylococcus aureus can promote oral squamous cell carcinoma growth through an IL-8–CXCR1 signaling relay. Its combination of MRSA-versus-MSSA vesicle comparisons, pathway analysis, genetic validation, and mouse tumor experiments identifies antibiotic-resistant bacterial vesicles as active regulators of tumor biology rather than passive infection-associated material.
-
Foretinib (GSK1363089) Cancer Assay Workflows
2026-08-23
Build more informative cancer drug-response studies with Foretinib by separating growth arrest from cell death and pairing proliferation, motility, and metastasis readouts. This workflow uses concentration-aware dosing, orthogonal endpoints, and model-specific controls to improve interpretation of a multikinase inhibitor.
-
AG-221 (Enasidenib): From 2-HG to Assay Design
2026-08-22
AG-221 (Enasidenib) provides a controlled way to connect mutant IDH2 inhibition with 2-hydroxyglutarate reduction, leukemia cell differentiation, and metabolic adaptation. This guide translates recent CD44 findings into a practical, resistance-aware assay strategy for acute myeloid leukemia research.
-
Oteseconazole (VT-1161) Candida Assay Guide
2026-08-22
Build reproducible Candida susceptibility assays with Oteseconazole (VT-1161), a selective fungal CYP51 inhibitor that remains useful against fluconazole-resistant strains. This guide connects concentration design, controls, transporter-aware interpretation, and troubleshooting to practical antifungal workflows.
-
Pravastatin sodium: Applied Research Workflows
2026-08-21
Pravastatin sodium enables controlled HMG-CoA reductase inhibition across enzyme, macrophage, hepatocyte, and LDL-handling assays. This workflow-focused guide combines concentration planning, transporter-aware controls, and troubleshooting strategies for more interpretable cholesterol biosynthesis studies.
-
Liproxstatin-1 HCl: Ferroptosis Assay Guide
2026-08-20
Build more discriminating ferroptosis assays with Liproxstatin-1 HCl, from lipid-peroxidation rescue experiments to mechanistic studies of the mitochondrial calcium–GPX4 axis. The workflow also shows how to separate ferroptotic rescue from nonspecific protection in renal and hepatic injury models.
-
LY2886721: From Target Engagement to Data
2026-08-20
LY2886721 is a potent BACE inhibitor for dissecting amyloid precursor protein processing and amyloid beta reduction. This guide presents an interpretation-first framework that connects biochemical activity, cellular biomarkers, neuronal function, and in vivo translational readouts.
-
Astrocytic GAT-3 in Dentate Gyrus Synaptic Plasticity
2026-08-19
The reference study identifies astrocytic GAT-3 as an active regulator of dentate gyrus synaptic transmission rather than merely a GABA-clearance transporter. By linking GAT-3-dependent astrocyte calcium signaling to presynaptic GluN2B-containing NMDA receptors and contextual fear memory, it provides a cellular mechanism connecting glial transport to hippocampal cognition.
-
Verapamil HCl Workflows for Calcium Signaling
2026-08-19
Verapamil HCl supports controlled studies of calcium-dependent excitability, apoptosis, inflammation, and bone turnover. This guide connects practical cell-based workflows with the reference study’s TXNIP-centered osteoporosis findings, while separating evidence-backed observations from optimization starting points.
-
Aβ40 as a Translational Model of Amyloid Biology
2026-08-18
Amyloid Beta-Peptide (1-40) (human) is more than an aggregation reagent: it is a controllable system for connecting peptide state, calcium-dependent membrane interactions, and disease-relevant phenotypes. This article outlines how translational researchers can use Aβ40 to build better mechanistic models, select meaningful controls, and interpret findings without overstating their clinical relevance.
-
HBTU Workflows for Responsive Peptide Design
2026-08-18
HBTU enables rapid, mild peptide bond formation for complex peptide sequences and enzyme-responsive amphiphiles. This guide connects solid phase peptide synthesis, reaction monitoring, troubleshooting, and assay translation while keeping synthetic performance distinct from biological validation.